ask="51.50"
ask_size="100"
average_daily_volume="406774"
bid="N/A"
bid_size="N/A"
book_value="14.89"
change="+0.79"
change_from_200_day_moving_average="-3.54"
change_from_50_day_moving_average="-2.01"
change_from_52_week_high="-14.38"
change_From_52_week_low="18.59"
change_in_percent="+1.72%"
close="46.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="24015000"
high="46.85"
high_52_weeks="60.98"
last_trade_date="2/1/2017"
last_trade_price="46.60"
last_trade_size="16983"
last_trade_time="4:00pm"
low="45.56"
low_52_weeks="28.01"
market_capitalization="1.26B"
moving_average_200_day="50.14"
moving_average_50_day="48.61"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="46.17"
pe_ratio="5.21"
peg_ratio="0.32"
percent_change_from_200_day_moving_average="-7.07%"
percent_change_from_50_day_moving_average="-4.13%"
percent_change_from_52_week_high="-23.58%"
percent_change_from_52_week_low="+66.37%"
previous_close="45.81"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.08"
price_per_sales="3.22"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.16"
stock_exchange="NMS"
symbol="FPRX"
volume="278325"
weeks_range_52="28.01 - 60.98"
